Washington Drug & Alcohol Commission Inc

Washington Drug & Alcohol Commission Inc shows consistent revenue-expense management with recent significant asset and liability growth.

EIN: 10671144 · Washington, PA · NTEE: F20 · Updated: 2026-03-28

$4.4MRevenue

$2.6MAssets

80/100Mission Score (Excellent)

F20

About Washington Drug & Alcohol Commission Inc

Washington Drug & Alcohol Commission Inc (EIN: 10671144) is a nonprofit organization based in Washington, PA, classified under NTEE code F20. The organization reported total revenue of $4.4M and total assets of $2.6M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Washington Drug & Alcohol Commission Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

Washington Drug & Alcohol Commission Inc demonstrates consistent financial activity, with revenues and expenses generally tracking closely over the past decade. In the latest period (202306), the organization reported revenues of $3,895,769 against expenses of $3,821,577, indicating a slight surplus. The organization's assets have shown significant growth, particularly between 202206 ($1,131,444) and 202306 ($2,517,131), while liabilities also increased substantially from $415,632 to $1,727,129 in the same period. This suggests potential investments or changes in financial structure that warrant further investigation.

The organization appears to be financially stable, consistently managing its expenses within its revenue streams. A notable aspect is the reported 0% officer compensation across all available filings, which could indicate that executive leadership is either volunteer-based, compensated through other means not reported as officer compensation, or that the organization's structure does not include traditional 'officer' roles with reportable compensation. This lack of reported executive compensation, while potentially positive for resource allocation, could also raise questions about the transparency of leadership remuneration if it exists in other forms. The substantial increase in both assets and liabilities in the most recent period suggests a significant financial event or strategic shift.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Washington Drug & Alcohol Commission Inc with a Mission Score of 80 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

admin: 10%
programs: 85%
fundraising: 5%

According to IRS 990 filings, Washington Drug & Alcohol Commission Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

The organization consistently reports 0% officer compensation across all available filings, which is unusual for an organization of its size and revenue. This suggests either a volunteer-led executive team or compensation structured in a way not reported as officer compensation on the 990.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Washington Drug & Alcohol Commission Inc's IRS 990 filings:

Consistent 0% reported officer compensation, which is unusual for an organization of this size and could indicate a lack of transparency regarding leadership remuneration.
Significant and sudden increase in liabilities (from $415,632 to $1,727,129) in the latest filing period without clear explanation in summary data, potentially indicating increased financial risk.

Strengths

The following positive indicators were identified for Washington Drug & Alcohol Commission Inc:

Consistent financial stability with revenues generally covering expenses over a decade.
Positive net assets, indicating financial solvency.
Strong program focus implied by the NTEE code (F20 - Substance Abuse Prevention & Treatment) and typical spending patterns for such organizations.
Significant asset growth in the latest period, potentially indicating successful capital campaigns or investments.

Frequently Asked Questions about Washington Drug & Alcohol Commission Inc

What caused the significant increase in assets and liabilities between 2022 and 2023?

Between the 202206 and 202306 periods, assets increased from $1,131,444 to $2,517,131, and liabilities increased from $415,632 to $1,727,129. This substantial change suggests a major financial event, such as a capital investment, acquisition, or significant loan, which would require reviewing the full 990 for details.

How does the organization compensate its leadership if officer compensation is consistently 0%?

The consistent reporting of 0% officer compensation across all filings is atypical. It could mean that executive roles are filled by volunteers, or that compensation for leadership is categorized differently within the 990, such as through independent contractor fees or other employee salaries not specifically designated as 'officer compensation'.

Is the organization's financial growth sustainable given the recent increase in liabilities?

While assets have grown, the corresponding increase in liabilities from $415,632 to $1,727,129 in one year warrants scrutiny. The sustainability depends on the nature of these liabilities (e.g., long-term debt vs. short-term payables) and the organization's ability to generate sufficient cash flow to service them.

Filing History

IRS 990 filing history for Washington Drug & Alcohol Commission Inc showing financial trends over 12 years of public records:

Over 12 years of IRS 990 filings (2012–2023), Washington Drug & Alcohol Commission Inc's revenue has grown by 55.6%, moving from $2.5M to $3.9M. Total assets increased by 278.3% over the same period, from $665K to $2.5M. Total functional expenses rose by 50.7%, from $2.5M to $3.8M. In its most recent filing year (2023), Washington Drug & Alcohol Commission Inc reported a surplus of $74K, with revenue exceeding expenses. The organization holds $1.7M in liabilities against $2.5M in assets (debt-to-asset ratio: 68.6%), resulting in net assets of $790K.

Year	Revenue	Expenses	Assets	Liabilities	Officer Comp.	PDF
2023	$3.9M	$3.8M	$2.5M	$1.7M	—	View 990
2022	$3.7M	$3.6M	$1.1M	$416K	—	View 990
2021	$3.7M	$3.6M	$1.3M	$634K	—	View 990
2020	$3.8M	$3.9M	$1.5M	$909K	—	View 990
2019	$4.3M	$4.4M	$1.2M	$528K	—	View 990
2018	$4.0M	$3.9M	$1.3M	$475K	—	View 990
2017	$3.2M	$3.2M	$872K	$133K	—	View 990
2016	$2.5M	$2.4M	$953K	$227K	—	View 990
2015	$2.6M	$2.6M	$793K	$228K	—	View 990
2014	$2.7M	$2.7M	$736K	$239K	—	View 990
2013	$2.4M	$2.4M	$667K	$210K	—	View 990
2012	$2.5M	$2.5M	$665K	$207K	—	View 990

Year-by-Year Financial Summary

2023: Revenue of $3.9M, expenses of $3.8M, and assets of $2.5M (revenue +5.4% year-over-year).
2022: Revenue of $3.7M, expenses of $3.6M, and assets of $1.1M (revenue +0.7% year-over-year).
2021: Revenue of $3.7M, expenses of $3.6M, and assets of $1.3M (revenue -4.3% year-over-year).
2020: Revenue of $3.8M, expenses of $3.9M, and assets of $1.5M (revenue -10.5% year-over-year).
2019: Revenue of $4.3M, expenses of $4.4M, and assets of $1.2M (revenue +7.9% year-over-year).
2018: Revenue of $4.0M, expenses of $3.9M, and assets of $1.3M (revenue +25.4% year-over-year).
2017: Revenue of $3.2M, expenses of $3.2M, and assets of $872K (revenue +24.8% year-over-year).
2016: Revenue of $2.5M, expenses of $2.4M, and assets of $953K (revenue -3.9% year-over-year).
2015: Revenue of $2.6M, expenses of $2.6M, and assets of $793K (revenue -2.3% year-over-year).
2014: Revenue of $2.7M, expenses of $2.7M, and assets of $736K (revenue +14.4% year-over-year).
2013: Revenue of $2.4M, expenses of $2.4M, and assets of $667K (revenue -5.5% year-over-year).
2012: Revenue of $2.5M, expenses of $2.5M, and assets of $665K.

Data Sources and Methodology

This transparency report for Washington Drug & Alcohol Commission Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.